|
Inmate Central Inmate Central, where civil and family-friendly discourse about off-audio topics (other than religion and politics) is welcome. |
|
|
|
Inmate Central Inmate Central, where civil and family-friendly discourse about off-audio topics (other than religion and politics) is welcome. |
|
In Reply to: I don't think Yahoo quite got all the story posted by Chris from Lafayette on July 21, 2020 at 14:33:02:
Did they conduct human challenge trials?
Human challenge trials would be pretty damn unethical considering there is no cure or consistently effective treatment for COVID-19, so I kind of doubt they did that, and haven't seen any new sources that said they did.
Without human challenge trials, the best they could say is that the vaccine stimulated antibody production. That's assumed to be an indicator of efficacy, but wouldn't support a claim that they've tested short-term efficacy.
What I did see a week ago was that they completed the first phase of human trials, consisting of ~20 individuals, which verified immune response and has so far not indicated safety concerns. That's good, but there are other teams further ahead in the process.
The more, the merrier I say. But all the boasting is a bit much.
This post is made possible by the generous support of people like you and our sponsors:
Follow Ups
- So how did they evaluate short-term efficacy? - Dave_K 07/21/2016:44:21 07/21/20 (1)
- As you probably know, there is pent-up demand for a vaccine - Chris from Lafayette 17:08:49 07/21/20 (0)
Top of Page ]
[ Contact Us ]
[ Support/Wish List ]
[ Copyright © 2024, Audio Asylum, all rights reserved ]
